Maoming Mengteng Trading Co., Ltd. – Trademark Portfolio

Entity Type: 16

Maoming Mengteng Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AZRYXODC. The owner is based in Dianbai, Maoming City.

No. 288 Yingbin Road, Dianhai Street

Room D-06-3, 5th Floor, Liutao Building

Dianbai, Maoming City 525400 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AZRYXODC
AZRYXODC
Registered 2024

Trademark Classifications

Maoming Mengteng Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Maoming Mengteng Trading Co., Ltd. have?

Maoming Mengteng Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Maoming Mengteng Trading Co., Ltd. file in?

Maoming Mengteng Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Maoming Mengteng Trading Co., Ltd.'s most well-known trademarks?

Maoming Mengteng Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as AZRYXODC. These are among 1 currently registered trademark in the portfolio.

What is Maoming Mengteng Trading Co., Ltd.'s trademark registration success rate?

Maoming Mengteng Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.